Niederacher D - Search Results

1

Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.

Glaeser M, Niederacher D, Djahansouzi S, Hanstein B, Dittrich R, Beckmann MW, Fasching PA, Ackermann S. Glaeser M, et al. Among authors: niederacher d. Anticancer Res. 2006 Jan-Feb;26(1B):735-44. Anticancer Res. 2006. PMID: 16739346 Free article.

2

ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues.

An HX, Niederacher D, Beckmann MW, Göhring UJ, Scharl A, Picard F, van Roeyen C, Schnürch HG, Bender HG. An HX, et al. Among authors: niederacher d. Int J Cancer. 1995 Oct 20;64(5):291-7. doi: 10.1002/ijc.2910640502. Int J Cancer. 1995. PMID: 7591299

3

[Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].

Beckmann MW, Tutschek B, Göhring UJ, Engels K, Picard FK, Scharl A, Niederacher D, Schnürch HG. Beckmann MW, et al. Among authors: niederacher d. Geburtshilfe Frauenheilkd. 1995 May;55(5):258-65. doi: 10.1055/s-2007-1023314. Geburtshilfe Frauenheilkd. 1995. PMID: 7607382 German.

4

[The erbB gene family: significance for tumor development, prognosis and new therapeutic modalities].

Beckmann MW, Niederacher D, Schnürch HG, Bender HG. Beckmann MW, et al. Among authors: niederacher d. Geburtshilfe Frauenheilkd. 1993 Nov;53(11):742-53. doi: 10.1055/s-2007-1023620. Geburtshilfe Frauenheilkd. 1993. PMID: 7904970 Review. German.

5

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.

Beckmann MW, Picard F, An HX, van Roeyen CR, Dominik SI, Mosny DS, Schnürch HG, Bender HG, Niederacher D. Beckmann MW, et al. Among authors: niederacher d. Br J Cancer. 1996 May;73(10):1220-6. doi: 10.1038/bjc.1996.234. Br J Cancer. 1996. PMID: 8630282 Free PMC article.

6

Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.

An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW. An HX, et al. Among authors: niederacher d. Genes Chromosomes Cancer. 1996 Sep;17(1):14-20. doi: 10.1002/(SICI)1098-2264(199609)17:1<14::AID-GCC3>3.0.CO;2-5. Genes Chromosomes Cancer. 1996. PMID: 8889502

7

Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patients.

Beckmann MW, Niederacher D, Massenkeil G, Tutschek B, Beckmann A, Schenko G, Schnürch HG, Bender HG. Beckmann MW, et al. Among authors: niederacher d. Oncology. 1996 Nov-Dec;53(6):441-7. doi: 10.1159/000227618. Oncology. 1996. PMID: 8960138

8

INT-2 gene amplification in differentiated human thyroid cancer.

Schulte KM, Niederacher D, An HX, Staudt S, Simon D, Beckmann MW, Goretzki PE. Schulte KM, et al. Among authors: niederacher d. Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:101-4. doi: 10.1055/s-0029-1211713. Exp Clin Endocrinol Diabetes. 1996. PMID: 8981013

9

Detection of sequential genetic alterations relevant for breast cancer development.

Niederacher D, Schnürch HG, An HX, Ellenberger I, Dall P, van Roeyen CR, Küppers V, Beckmann MW. Niederacher D, et al. Eur J Cancer Prev. 1996 Dec;5(6):497-503. Eur J Cancer Prev. 1996. PMID: 9061283

10

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.

Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW. Niederacher D, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):181-92. doi: 10.1002/(sici)1098-2264(199703)18:3<181::aid-gcc5>3.0.co;2-y. Genes Chromosomes Cancer. 1997. PMID: 9071571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page